| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| HSF1 |
HepG2 (hepatoblastoma) |
low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EET
|
MA0486.2
|
| HSF1 |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR009MBP
|
MA0486.2
|
| HSF1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR062HDL
|
MA0486.2
|
| HTH |
whole organism (development stage: embryonic) |
strain: p53-MiMIC-GFP, genotype: y[1] w[*]; Mi{eGFP=MIC}p53[MI01307]/TM6B, sb, Tb, Hu, sex:mixed |
Permissive
|
Drosophila melanogaster |
ENCSR808XNJ
|
MA0227.1
|
| HTH |
whole organism (development stage: embryonic) |
strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1] |
Permissive
|
Drosophila melanogaster |
ENCSR151VMK
|
MA0227.1
|
| HTH |
whole organism (development stage: embryonic) |
strain: yellow cinnabar brown speck, genotype: iso-1 : y[1]; Gr22b[1] Gr22d[1] cn[1] CG33964[R4.2] bw[1] sp[1]; LysC[1] MstProx[1] GstD5[1] Rh6[1], sex:mixed |
Permissive
|
Drosophila melanogaster |
ENCSR249JVE
|
MA0227.1
|
| IRF1 |
K562 (myelogenous leukemia) |
Interferon gamma treatment - 30 minutes (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EGK
|
MA0050.2
|
| IRF1 |
K562 (myelogenous leukemia) |
Interferon alpha treatment - 6 hours (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EGL
|
MA0050.2
|
| IRF1 |
K562 (myelogenous leukemia) |
Interferon gamma treatment - 6 hours (Snyder) |
Permissive
|
Homo sapiens |
ENCSR000EGT
|
MA0050.2
|
| IRF1 |
K562 (myelogenous leukemia) |
30 m of Interferon alpha (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EGU
|
MA0050.2
|
Showing 10 records in page 73
from 136 pages